Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.
2.
3.

Maggot debridement therapy (MDT) for burn wounds.

Summers JB, Kaminski J.

Burns. 2003 Aug;29(5):501-2. No abstract available.

PMID:
12880736
5.

Persisters, relapse (reactivation), drug resistance and multidrug therapy (MDT): uniform diagnostic guidelines for leprosy are needed.

Sehgal VN, Jain S, Charya SN.

J Dermatol. 1996 Dec;23(12):905-7. No abstract available.

PMID:
9037926
7.

Development of life-threatening thrombocytopaenia in a patient on MDT and prednisolone.

Croft R.

Lepr Rev. 1996 Sep;67(3):229. No abstract available. Erratum in: Lepr Rev 1996 Dec;67(4):356. Cross R [corrected to Croft R].

PMID:
8885619
8.

Profile of relapses after MDT in paucibacillary leprosy and subsequent management.

Vijayakumaran P.

Indian J Lepr. 1996 Jul-Sep;68(3):300-3. No abstract available.

PMID:
8889618
9.

Impact of MDT on incidence rates of leprosy among household contacts. Part 1. Baseline data.

Sundar Rao PS, Jesudasan K, Mani K, Christian M.

Int J Lepr Other Mycobact Dis. 1989 Sep;57(3):647-51.

PMID:
2778370
10.

Impact of MDT on leprosy as measured by selective indicators.

Jesudasan K, Vijayakumaran P, Pannikar VK, Christian M.

Lepr Rev. 1988 Sep;59(3):215-23. No abstract available.

PMID:
3264374
11.

Blister calendar packs for the treatment of patients in leprosy control programmes with multiple drug therapy (MDT)

Revankar CR, Sørensen BH.

Lepr Rev. 1988 Mar;59(1):84. No abstract available.

PMID:
3398681
12.

After multidrug therapy (MDT): who is responsible for continuing care?

Neville J.

Lepr Rev. 1988 Mar;59(1):1-3. No abstract available.

PMID:
2840537
13.

The impact of MDT implementation in the Tanzania National TB-Leprosy Programme.

Chum HJ.

Lepr Rev. 1986;57 Suppl 3:63-6. No abstract available.

PMID:
3573963
14.

The use of MDT in the three western regions of Nepal.

Kalthoff PG.

Lepr Rev. 1986;57 Suppl 3:106-14. No abstract available.

PMID:
3573950
15.

Preliminary evaluation of the effect of WHO-MDT on disabilities in leprosy patients in Malaŵi (Central Africa).

Boerrigter G, Ponnighaus JM.

Lepr Rev. 1986;57 Suppl 3:101-5. No abstract available.

PMID:
3573949

Supplemental Content

Loading ...
Support Center